News
Board-certified medical oncologist and hematologist joins physician teamHOT SPRINGS, Ark., Aug. 06, 2025 (GLOBE NEWSWIRE) -- ...
Conway Hematology Oncology (CHO), a trusted provider of hematology and oncology care in Conway, Arkansas, is proud to ...
With the field of HER2-positive breast cancer evolving rapidly, how will practice change in the clinic after the recent ...
More and more providers are beginning to incorporate the new Practical Geriatric Assessment into their practices.
The FDA approved an investigational new drug application for ABT-301, clearing the way for a new clinical trial in metastatic ...
Genmab Announces Financial Results for the First Half of 2025August 7, 2025 Copenhagen, Denmark; Interim Report for the First Half Ended June 30, 2025HighlightsEpcoritamab advancing to earlier lines ...
Experts debate which patients with stage III dMMR colon cancer will benefit from the two treatment approaches.
Following a national search, Joseph Contessa has been selected as the chair of radiation oncology for Rutgers Cancer ...
Key opinion leader event and pancreatic cancer clinical data validate decision to engage with regulators on plans for a registration-enabling study New members of the ...
I became a doctor because I lost someone I loved. I stayed because I believe in what we do together,” writes art director ...
Researchers tested more than 65,000 patients with more than 30 solid tumor types and found the rate of HER2 positivity was about 3%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results